“First-In-Human Evaluation Of The Safety And Immunogenicity Of A Recombinant Adenovirus Serotype 26 Hiv-1 Env Vaccine (Ipcavd 001).”. J Infect Dis 207 (2). J Infect Dis: 240-7. doi:10.1093/infdis/jis670.
. 2013. “First-In-Human Evaluation Of A Hexon Chimeric Adenovirus Vector Expressing Hiv-1 Env (Ipcavd 002).”. J Infect Dis 210 (7). J Infect Dis: 1052-61. doi:10.1093/infdis/jiu217.
. 2014.